Evidence map›Paper›PMID 28389798›Full record

SynthesisSurgical endoscopy2017

Total robotic pancreaticoduodenectomy: a systematic review of the literature.

Michail Kornaropoulos, Demetrios Moris, Eliza W Beal, Marinos C Makris, Apostolos Mitrousias, Athanasios Petrou, Evangelos Felekouras, Adamantios Michalinos, Michail Vailas, Dimitrios Schizas and 1 more

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Surgical endoscopy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Robot-assisted radical cholecystectomy for gallbladder cancer: A review.Journal of clinical and translational research · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michail Kornaropoulos1st Department of Surgery, "G. Genimatas" General Hospital, Athens, Greece.
Demetrios MorisLerner Research Institute, Cleveland Clinic, 9500 Euclid Ave., NE60, Cleveland, OH, 44195, USA. dimmoris@yahoo.com.
Eliza W BealDivision of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute, Columbus, OH, USA.
Marinos C Makris1st Department of Surgery, "G. Genimatas" General Hospital, Athens, Greece.
Apostolos Mitrousias1st Department of Surgery, "G. Genimatas" General Hospital, Athens, Greece.
Athanasios PetrouHepatobiliary and Surgical Oncology Department, Nicosia Teaching Hospital, Nicosia, Cyprus.
Evangelos Felekouras1st Department of Surgery, Laikon General Hospital, Athens, Greece.
Adamantios Michalinos1st Department of Surgery, Laikon General Hospital, Athens, Greece.
Michail Vailas1st Department of Surgery, Laikon General Hospital, Athens, Greece.
Dimitrios Schizas1st Department of Surgery, Laikon General Hospital, Athens, Greece.
Alexandros Papalampros1st Department of Surgery, Laikon General Hospital, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPancreaticoduodenectomy (PD) is a complex operation with high perioperative morbidity and mortality, even in the highest volume centers. Since the development of the robotic platform, the number of reports on robotic-assisted pancreatic surgery has been on the rise. This article reviews the current state of completely robotic PD. MATERIALS AND

methodsA systematic literature search was performed including studies published between January 2000 and July 2016 reporting PDs in which all procedural steps (dissection, resection and reconstruction) were performed robotically.

resultsThirteen studies met the inclusion criteria, including a total of 738 patients. Data regarding perioperative outcomes such as operative time, blood loss, mortality, morbidity, conversion and oncologic outcomes were analyzed. No major differences were observed in mortality, morbidity and oncologic parameters, between robotic and non-robotic approaches. However, operative time was longer in robotic PD, whereas the estimated blood loss was lower. The conversion rate to laparotomy was 6.5-7.8%.

conclusionsRobotic PD is feasible and safe in high-volume institutions, where surgeons are experienced and medical staff are appropriately trained. Randomized controlled trials are required to further investigate outcomes of robotic PD. Additionally, cost analysis and data on long-term oncologic outcomes are needed to evaluate cost-effectiveness of the robotic approach in comparison with the open technique.

Indexed as

FemaleHumansLength of StayMaleOperative TimePancreatic NeoplasmsPancreaticoduodenectomyPostoperative ComplicationsRoboticsRobotic Surgical ProceduresDa VinciMinimally invasiveOpenPancreaticoduodenectomyPancreatic surgeryRoboticRoboticsWhipple procedure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.